This isn’t a political issue, it’s a public health challenge with real consequences for kids’ futures. As reality sets in, we must face the possibility of a post-fluoridation era and find new ways to give kids in at-risk communities a fair shot at a healthy smile. The post Beyond Politics: Payer Solutions for Fluoride-free Communities…
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs and reduced access to healthcare in vulnerable communities. The post What’s Next for Walgreens Following its Private Equity Sale? appeared first on MedCity News.
With positive Phase 1 results for the metabolic disorder drug MZE782, Maze Therapeutics plans to advance the small molecule to Phase 2 tests in phenylketonuria and chronic kidney disease. Following the data readout, Maze raised $150 million in a private placement. The post Maze Therapeutics Drug Shows Potential to Top Asset Acquired by Otsuka for…
Healthcare groups are pushing back on CMS’ proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in a new value-based model. Organizations including MGMA, NAACOS and Premier are calling on the agency to revise its plan. The post Industry Groups Warn CMS’ 2026 Fee Schedule Could Undermine…
Putting aside the politics of this situation for the moment, here are some ways for commercial execs to navigate the current climate of volatility. The post How Pharma Marketers Can Prepare for Trump’s 200% Tariff Threat appeared first on MedCity News.
The longer we delay, the further we shift costs from polluters to patients — and to every taxpayer who funds Medicare, Medicaid and community hospitals. Environmental stewardship and human health are inseparable; regulating microplastics is preventive medicine on a national scale. The post Microplastics Are in Our Blood — Why Aren’t Federal Regulators Acting? appeared…
Penguin Ai raised $29.7 million for its AI platform aimed at automating costly administrative tasks like prior authorization and medical coding. CEO Fawad Butt said the startup’s goal is to move beyond point solutions and create an “Epic of the healthcare back office.” The post Penguin Ai Snags $30M to Simplify Prior Auth, Coding and…